Overview

Albumin-bound Paclitaxel Combined With Liposomal Doxorubicin in the Treatment of Advanced or Unresectable Angiosarcoma

Status:
Not yet recruiting

Trial end date:
2023-05-20

Target enrollment:

Participant gender:

Summary

The purpose is to explore the efficacy and safety of the combination of albumin-bound paclitaxel and liposomal doxorubicin in the treatment of advanced or unresectable angiosarcoma.

Phase:

Phase 2

Details

Lead Sponsor:

Sun Yat-sen University

Treatments:

Albumin-Bound Paclitaxel
Doxorubicin
Liposomal doxorubicin